CClinicalTrials.gg
WithdrawnNCT06234059Updated Jul 29, 2025

Modulation of Sensory Acuity With Transcranial Magnetic Stimulation (TMS)

An interventional study of TMS and Speaking Tasks in Speech, sponsored by University of Wisconsin, Madison. Withdrawn at 1 site in United States. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-07-29.

Sponsored by University of Wisconsin, Madison · Not applicable, Interventional, and Basic science

Why this study was withdrawn
Another research group ran a similar study and reported results
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Not applicable
Ages
18 Years to 70 Years
Sex
All
01

Study summary

The purpose of this research study is to understand how the brain processes and controls speech in healthy people. The investigators are doing this research because it will help identify the mechanisms that allow people to perceive their own speech errors and to learn new speech sounds, which may be applied to people who have communication disorders. 15 participants will be enrolled into this part of the study and can expect to be on study for 4 visits of 2-4 hours each.

Read the detailed description

The overall study (Establishing the clinical utility of sensorimotor adaptation for speech rehabilitation) aims to understand how cognitive, perceptual, and motor processes are integrated in the control of speech movements. The investigators study how this complex skill is performed in healthy speakers to understand how this system functions, how this skill relates to the perception of speech, and what role different parts of the brain play in this process. Different studies look at how speech motor control is executed, maintained, and changed. Overall, the study will recruit 329 participants over the course of 5 years. Participants can expect to be on study for up to 3 weeks.

The entire study is composed of 8 experiments and 6 interventions. The present record represents the experiments involving transcranial magnetic stimulation (TMS), i.e. Experiment 8: Modulating sensorimotor adaptation through TMS to somatosensory cortex.

This paradigm uses theta-burst transcranial magnetic stimulation (tbTMS) to modulate the excitability of sensory cortices to examine the effect on sensory acuity and sensorimotor adaptation. Participants will complete three total sessions targeting primary somatosensory cortex (S1): one using intermittent theta-burst stimulation (iTBS), one using continuous theta-burst stimulation (cTBS), and one with sham stimulation.

The effect of the stimulation on somatosensory adaptation will be measured using a vowel centralization feedback perturbation experiment: after stimulation, participants will produce words under conditions of altered auditory feedback, and the investigators will measure changes in produced vowels as a result of these alterations.

02

Conditions studied

  • Speech

Browse trials for

Keywords

  • speech motor control
  • vocal learning
03

In context

Speech

67 studies on the registry are indexed under Speech; 46 are open to participants now.

Browse Speech studies →

Lead sponsor

University of Wisconsin, Madison is the lead sponsor of 1,161 studies on the registry; 182 are open to participants now.

Of its 151 completed or terminated interventional studies of FDA-regulated products, 114 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • English-speaking adults
  • normal hearing and speech
  • no history of stroke or neurological conditions

Exclusion criteria

Exclusion Criteria:

  • Native language other than English
  • Any neurological disorders other than the disorder of interest
  • Any history of hearing disorders
  • Uncorrected vision problems that prevent participants from seeing visually-presented stimuli
  • Significant cognitive impairments that prevent participants from carrying out the task or from giving informed consent
  • Vulnerable populations (minors and prisoners)
  • Additional exclusionary criteria for TMS:

    • Implanted paramagnetic materials (metal clips, plates, pacemakers, etc.)
    • Increased risk in the event of a seizure
    • Serious heart disease
    • Increased intracranial pressure
    • Pregnancy
    • History of seizures
    • Family history of epilepsy
    • Epileptogenic medications
    • Chronic or transient disruption of sleep (including jet lag)
    • History of fainting
    • Chronic or transient increase in stressful experiences
    • Use of illegal drugs
    • If the TMS visit involves a visual acuity task at the same time as TMS] Use of glasses at the research study visit
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
0 participants (actual)

Study arms

  • Experimental
    Healthy Adult Speakers

    healthy adult participants across the lifespan in three groups:18-35, 36-55, and 56+

    Device: TMS · Behavioral: Speaking Tasks

Interventions

  • DeviceTMS

    This paradigm uses theta-burst transcranial magnetic stimulation (tbTMS) to modulate the excitability of sensory cortices to examine the effect on sensory acuity and sensorimotor adaptation. Participants will complete three total sessions targeting primary somatosensory cortex (S1): one using intermittent theta-burst stimulation (iTBS), one using continuous theta-burst stimulation (cTBS), and one with sham stimulation.

    Also known as: transcranial magnetic stimulation (continuous and intermittent theta-burst stimulation), electromyography (EMG)

  • BehavioralSpeaking Tasks

    Participants will produce four training words under a vowel centralization feedback paradigm in which auditory feedback is altered. The investigators will measure changes in produced vowels as a result of the altered feedback in concert with the different stimulation regimes described in the TMS intervention.

06

What researchers measure

Primary outcomes

  1. Acoustic vowel space measures: AVS (acoustic vowel spacing)/VSA (vowel space area)

    For speech production tasks, the primary acoustic measure will be adaptation to the altered feedback, defined here as increases in AVS (average vowel spacing), the mean of pairwise formant distances between vowels. The investigators will also include a global measure of working vowel space, the quadrilateral vowel space area (qVSA). qVSA measures the area (in Hz\^2) between the F1/F2 coordinates of the corner vowels. Both the more local AVS and more global qVSA have been linked to speech intelligibility in various types of dysarthria.

    Time frame: up to 1 hour

07

Study locations

1 site
  • University of Wisconsin
    Madison, Wisconsin 53705, United States
08

References and documents

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 29, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06234059
Lead sponsor
University of Wisconsin, Madison
Collaborators
National Institute on Deafness and Other Communication Disorders (NIDCD)
Responsible party
Sponsor
First posted
Jan 31, 2024
Start date
Jul 2025 (estimated)
Primary completion
Jul 2026 (estimated)
Completion
Jul 2026 (estimated)
Last update
Jul 29, 2025

Study contacts

Carrie Niziolek, PhD
principal investigator · University of Wisconsin, Madison

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion